WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (OTC BB: NNVC) (the “Company”) announced today that it will be leasing new space for cGMP production of its nanoviricides® drug candidates against various viral diseases. The Company is planning to lease the space with an option for a future purchase from Inno-Haven LLC, a special purpose company formed for the acquisition of a facility and construction of appropriate laboratory and manufacturing facilities.
